FDA – Comments Submitted to FDA on Patient Preference Information – Submission, Review in PMAs, HDE Applications and De Novo Requests, and Inclusion in Device Labeling

Comments Submitted to FDA on Patient Preference Information – Submission, Review in PMAs, HDE Applications and De Novo Requests, and Inclusion in Device Labeling. (Docket Number: FDA-2015-D-1580-0001).

Click here to read the comments and impact on ACRP Members.